Literature DB >> 7594574

Gamma delta T cells in the pathobiology of murine acute graft-versus-host disease. Evidence that gamma delta T cells mediate natural killer-like cytotoxicity in the host and that elimination of these cells from donors significantly reduces mortality.

C A Ellison1, G C MacDonald, E S Rector, J G Gartner.   

Abstract

NK-like cytotoxicity in F1-hybrid mice with acute GVH disease is mediated by donor-derived CD3+/CD4-/CD8- cells that can lyse both NK-sensitive YAC-1 target cells as well as NK-resistant targets such as BW1100 and P815. Our objective was to determine whether this activity is mediated by gamma delta TCR+ cells. We showed that NK-like cytotoxic activity in the spleen and lymph nodes of mice with acute GVH disease could be depleted by indirect complement-mediated lysis using an Ab against gamma delta TCR. When purified NK1.1+ spleen cells that had been positively selected on a magnetic cell separator were used as effector cells, we found that NK-like cytotoxicity was mediated only by gamma delta TCR+ cells, suggesting that cells with NK-like activity are gamma delta TCR+/NK1.1+. We showed by flow cytometry experiments that coexpression of NK1.1 and TCR-gamma delta occurred on a large proportion of large granular lymphocytes in the spleens of GVH mice, but was not detectable in normal control mice. In GVH mice, fewer than 10% of small agranular NK1.1+ lymphocytes coexpressed NK1.1+ and gamma delta TCR+. On the basis of this hypothesis, we postulate that graft-derived large granular lymphocytes develop the NK1.1+/gamma delta TCR+ phenotype during the reaction, and that these cells play a role in the pathogenesis of acute GVH disease. We performed experiments to determine whether depletion of gamma delta T cells from donor mice affected the outcome of lethal GVH disease and found that there was a significant reduction in mortality.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7594574

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Critical role of host gammadelta T cells in experimental acute graft-versus-host disease.

Authors:  Yoshinobu Maeda; Pavan Reddy; Kathleen P Lowler; Chen Liu; Dennis Keith Bishop; James L M Ferrara
Journal:  Blood       Date:  2005-03-29       Impact factor: 22.113

Review 2.  T cell optimization for graft-versus-leukemia responses.

Authors:  Melinda A Biernacki; Vipul S Sheth; Marie Bleakley
Journal:  JCI Insight       Date:  2020-05-07

Review 3.  Antigen-presenting cell engineering. The molecular toolbox.

Authors:  M L Tykocinski; D R Kaplan; M E Medof
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

4.  Palifermin mediates immunoregulatory effects in addition to its cytoprotective effects in mice with acute graft-versus-host disease.

Authors:  Cynthia A Ellison; Bryce M Makar; Jacqie M M Wiseman; Ionela Gheorghiu; Masaru Taniguchi; John G Gartner
Journal:  J Clin Immunol       Date:  2008-07-01       Impact factor: 8.317

Review 5.  Immunoregulatory cells for transplantation tolerance and graft-versus-leukemia effect.

Authors:  Masahiro Imamura; Junji Tanaka
Journal:  Int J Hematol       Date:  2003-10       Impact factor: 2.490

6.  Phenotypic and functional modulation of T cells in vivo by extrathymic T cells when T cells with MHC class II disparity were injected into athymic nude mice.

Authors:  K Tomiyama; H Watanabe; S Seki; M Ito; T Abo
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

7.  Lack of functional TSLP receptors mitigates Th2 polarization and the establishment and growth of 4T1 primary breast tumours but has different effects on tumour quantities in the lung and brain.

Authors:  R B Erdmann; J G Gartner; W J Leonard; C A Ellison
Journal:  Scand J Immunol       Date:  2013-11       Impact factor: 3.487

8.  Granulocyte colony-stimulating factor affects the distribution and clonality of TRGV and TRDV repertoire of T cells and graft-versus-host disease.

Authors:  Li Xuan; Xiuli Wu; Yu Zhang; Zhiping Fan; Yiwen Ling; Fen Huang; Fuhua Zhang; Xiao Zhai; Qifa Liu
Journal:  J Transl Med       Date:  2011-12-15       Impact factor: 5.531

9.  Innate Immune Determinants of Graft-Versus-Host Disease and Bidirectional Immune Tolerance in Allogeneic Transplantation.

Authors:  Anouk A J Hamers; Sunil K Joshi; Asha B Pillai
Journal:  OBM Transplant       Date:  2019-01-31

10.  Donor γδT Cells Promote GVL Effect and Mitigate aGVHD in Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Yuan Song; Ying Zhu; Bo Hu; Yonghao Liu; Dandan Lin; Ziqi Jin; Zhinan Yin; Chen Dong; Depei Wu; Haiyan Liu
Journal:  Front Immunol       Date:  2020-10-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.